Lilly Korea to introduce Cialis via co-marketing with Daewoong Pharm

Business sources say that the domestic anti-impotence drug market, which is estimated at 50.0 billion won in size, has emerged as an arena of bipartite competition - Pfizer's Viagra and Eli Lilly's Cialis.

Lilly Korea announced that it signed with Daewoong Pharm, a long-standing business partner in Korea, a co-marketing agreement of Cialis to be launched at the end of this month. The drug is...